Fleet Phospho Soda Alleged to Cause Kidney Problems
FREE CASE REVIEW |
Often taken by patients in preparation for a colonoscopy, Fleet brand Phospho Soda may be linked to kidney failure in patients who used the product previously available over the counter.
If you used Fleet Phospho Soda and have since experienced kidney problems or renal failure the please contact our attorneys now at 800-529-5072 or complete the easy form on this page.
Fleet brand Phospho Soda is one of a class of products known as OSP's which stands for Oral Sodium Phosphate. On 12/11/08 the FDA issued an alert for these products which warns of potential kidney failure. An excerpt from that FDA Alert is below.
"FDA has become aware of reports of acute phosphate nephropathy, a type of acute kidney injury, associated with the use of oral sodium phosphate products (OSP) for bowel cleansing prior to colonoscopy or other procedures. These products include the prescription products, Visicol and OsmoPrep, and OSPs available over-the-counter without a prescription as laxatives (e.g., Fleet Phospho-soda). In some cases when used for bowel cleansing, these serious adverse events have occurred in patients without identifiable factors that would put them at risk for developing acute kidney injury. We cannot rule out, however, that some of these patients were dehydrated prior to ingestion of OSP's or they did not drink sufficient fluids after ingesting OSP." Source: www.fda.gov/cder/drug/infopage/OSP_solution/
Phosphate nephropathy is the medical term which describes how damage to the kidneys can result from oral sodium phosphate products. The FDA also published a Science Background Paper about phosphate nephropathy and the association with oral sodium phosphate products. An excerpt from that paper and link are provided below.
"Healthcare professionals should be aware that acute phosphate nephropathy, a type of acute renal failure, is a rare, but serious adverse event associated with the use of oral sodium phosphate (OSP) products for bowel cleansing. Documented cases of acute phosphate nephropathy include 21 patients who used an OSP solution (such as Fleet Phospho-soda and Fleet ACCU-PREP) and one patient who used OSP tablets (Visicol). The bowel cleansing doses of OSP solutions (two 45 mL doses taken 10-12 hours apart) and Visicol (40 tablets) provide nearly identical amounts of sodium phosphate: about 60 grams of sodium phosphate per dose. No cases of acute phosphate nephropathy have been associated with OsmoPrep, an OSP tablet bowel preparation (containing 48 grams of sodium phosphate), approved in March 2006." Source: www.fda.gov/cder/drug/infopage/OSP_solution/backgrounder.htm
If you suspect a Fleet Phospho Soda may be linked to your kidney problems then contact our attorneys now by calling 800-529-5072 or by completing the Case Review form on this page. A fast and free legal case review will determine if you might be eligible to receive financial compensation.
Previous page: Fen-Phen
Next page: Fosamax and ONJ


